Jordan Diabetes Microclinic Project
|Study Design:||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Pilot and Expansion Project for the Jordan Diabetes Microclinic Project|
- Weight (kg) [ Time Frame: Baseline, 4 months (intervention), and 12 months (post-intervention) ] [ Designated as safety issue: No ]Change in weight overtime
- Fasting Blood Glucose (mg/dl) [ Time Frame: Baseline, 4 months, 12 months ] [ Designated as safety issue: No ]Change in fasting blood glucose overtime
- Hemoglobin A1c (%, HBA1c) [ Time Frame: Baseline, 4 months, 12 months ] [ Designated as safety issue: No ]Change in HBA1c overtime
- Body Mass Index (kg/m2) [ Time Frame: Baseline, 4 months, 12 months ] [ Designated as safety issue: No ]Change in body mass index overtime
|Study Start Date:||April 2008|
|Study Completion Date:||August 2012|
|Primary Completion Date:||April 2011 (Final data collection date for primary outcome measure)|
Experimental: Microclinics training
Diabetic, pre-diabetic, or those with family members who are diabetic/pre-diabetic who participated in a 4 month long intervention with a focus on disease management, health behavior change, and social network supports in order to improve chronic disease risk factors.
Microclinics consist of 2-8 individuals from pre-existing social networks (friends, relatives, coworkers, neighbors, etc) that voluntarily participate in ongoing education and medical monitoring from local health care professionals, learning and practicing diabetes management strategies, sharing much-needed medical supplies, and exchanging social support in the form of regular microclinic meetings.
The Global Microclinic Project seeks to empower people to prevent and manage diseases in economically depressed areas Jordan. The project seeks to more broadly link health education opportunities in the form of lectures and seminars with practical experience through workshops and hands-on learning, ultimately resulting in the creation of microclinics. Microclinics are intimate support groups of diabetic patients (2-8 per clinic) who meet in their homes and businesses in order to share the costs of maintaining medical monitoring equipment and supplies, come together to support one another in the management of diabetes, collectively utilize vital treatment options, and receive personalized screening, education and management tools from medical professionals.
The microclinics concept is ideal for the management of chronic disorders such as diabetes, a disease which requires ongoing education about diet and exercise and regular monitoring of health indices such as blood glucose levels and weight change. Indeed, the microclinics model has been established successfully in the West Bank specifically to combat diabetes. The goal here is to extend the model to Jordan and to establish microclinics in a collaborative effort with the Royal Health Awareness Society (RHAS) and the Jordanian Ministry of Health (MoH).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01596244
|Ein El-Basha Ministry of Health Center|
|Jabl Nasr Ministry of Health Center|
|Principal Investigator:||Daniel Zoughbie, DPhil||Microclinic International|
|Principal Investigator:||Eric Ding, PhD||Harvard University|